169 related articles for article (PubMed ID: 25685850)
1. Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.
Mannino DM; Tal-Singer R; Lomas DA; Vestbo J; Graham Barr R; Tetzlaff K; Lowings M; Rennard SI; Snyder J; Goldman M; Martin UJ; Merrill D; Martin AL; Simeone JC; Fahrbach K; Murphy B; Leidy N; Miller B
Chronic Obstr Pulm Dis; 2015; 2(1):23-34. PubMed ID: 25685850
[TBL] [Abstract][Full Text] [Related]
2. Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.
Miller BE; Tal-Singer R; Rennard SI; Furtwaengler A; Leidy N; Lowings M; Martin UJ; Martin TR; Merrill DD; Snyder J; Walsh J; Mannino DM
Am J Respir Crit Care Med; 2016 Mar; 193(6):607-13. PubMed ID: 26745765
[TBL] [Abstract][Full Text] [Related]
3. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
[TBL] [Abstract][Full Text] [Related]
4. End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
Manon-Jensen T; Langholm LL; Rønnow SR; Karsdal MA; Tal-Singer R; Vestbo J; Leeming DJ; Miller BE; Bülow Sand JM
Respir Med; 2019; 160():105814. PubMed ID: 31739246
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
6. St George's Respiratory Questionnaire Score Predicts Outcomes in Patients with COPD: Analysis of Individual Patient Data in the COPD Biomarkers Qualification Consortium Database.
Müllerova H; Gelhorn H; Wilson H; Benson VS; Karlsson N; Menjoge S; Rennard SI; Tabberer M; Tal-Singer R; Merrill D; Jones PW
Chronic Obstr Pulm Dis; 2017 Mar; 4(2):141-149. PubMed ID: 28848923
[No Abstract] [Full Text] [Related]
7. Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
Mannino DM; Valvi D; Mullerova H; Tal-Singer R
COPD; 2012 Aug; 9(4):359-66. PubMed ID: 22489912
[TBL] [Abstract][Full Text] [Related]
8. The COPD Biomarker Qualification Consortium (CBQC).
Casaburi R; Celli B; Crapo J; Criner G; Croxton T; Gaw A; Jones P; Kline-Leidy N; Lomas DA; Merrill D; Polkey M; Rennard S; Sciurba F; Tal-Singer R; Stockley R; Turino G; Vestbo J; Walsh J
COPD; 2013 Jun; 10(3):367-77. PubMed ID: 23713597
[TBL] [Abstract][Full Text] [Related]
9. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
[TBL] [Abstract][Full Text] [Related]
10. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.
Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J
Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen and α1-antitrypsin in COPD exacerbations.
Ingebrigtsen TS; Marott JL; Rode L; Vestbo J; Lange P; Nordestgaard BG
Thorax; 2015 Nov; 70(11):1014-21. PubMed ID: 26304913
[TBL] [Abstract][Full Text] [Related]
12. Long-term Course of Depression Trajectories in Patients With COPD: A 3-Year Follow-up Analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Cohort.
Yohannes AM; Müllerová H; Hanania NA; Lavoie K; Tal-Singer R; Vestbo J; Rennard SI; Wouters EF
Chest; 2016 Apr; 149(4):916-26. PubMed ID: 26836938
[TBL] [Abstract][Full Text] [Related]
13. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
14. Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease.
Hyun DG; Oh YM; Lee SW; Lee SD; Lee JS
J Korean Med Sci; 2019 Jul; 34(29):e195. PubMed ID: 31347309
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.
Søgaard M; Madsen M; Løkke A; Hilberg O; Sørensen HT; Thomsen RW
Int J Chron Obstruct Pulmon Dis; 2016; 11():455-65. PubMed ID: 27042038
[TBL] [Abstract][Full Text] [Related]
16. The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.
Celli B; Tetzlaff K; Criner G; Polkey MI; Sciurba F; Casaburi R; Tal-Singer R; Kawata A; Merrill D; Rennard S;
Am J Respir Crit Care Med; 2016 Dec; 194(12):1483-1493. PubMed ID: 27332504
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
18. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
[TBL] [Abstract][Full Text] [Related]
19. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN
Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
